Keywords: astrazeneca, seloken, oked, heart, failure, been, granted

AstraZeneca's Seloken OKed for heart failure

Article | 25 April 2000

AstraZeneca has been granted clearance in Denmark to market its betablocker Seloken ZOK (metoprolol controlled-release) for the treatment of heart ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Astra Zeneca

AstraZeneca

Go to company listing